Table 7.

CUA (lifelong). Subgroups

Intervention strategies	N	Costs (€/patient)		Effect (per patient)		ICER
		Mean	[95% CI]	Mean	[95% CI]	Mean	[95% CI]
Age < 50				QALYs		€/QALY
CO-PCI	17	51,900	[38,600, 74,700]	7.88	[2.18, 13.5]
MV-PCI	16	42,800	[31,100, 55,500]	7.8	[2.23, 13.5]
CO-PCI vs. MV-PCI	33	9090	[− 8240, 30,400]	0.0774	[− 2.16, 1.97]	117,000	[− 286,000, 153,000]
Age 50–75				QALYs		€/QALY
CO-PCI	212	38,600	[33,400, 52,600]	3.91	[1.45, 7.03]
MV-PCI	227	36,100	[32,500, 42,300]	3.62	[1.32, 6.21]
CO-PCI vs. MV-PCI	439	2500	[− 3610, 12,800]	0.295	[− 0.953, 1.73]	8500	[− 84,000, 108,000]
Age > 75				QALYs		€/QALY
CO-PCI	115	17,500	[13,600, 23,700]	0.947	[0.258, 2.65]
MV-PCI	99	17,800	[13,500, 23,200]	0.744	[0.275, 1.98]
CO-PCI vs. MV-PCI	214	− 226	[− 6970, 7010]	0.203	[− 0.335, 1.05]	CO-PCI dominates
Female				QALYs		€/QALY
CO-PCI	86	21,800	[15,500, 35,100]	3.21	[1.21, 5.88]
MV-PCI	75	19,000	[14,700, 25,900]	2.86	[1.04, 5.06]
CO-PCI vs. MV-PCI	161	2810	[− 4610, 14,200]	0.347	[− 0.734, 1.6]	8080	[− 95,300, 105,000]
Male				QALYs		€/QALY
CO-PCI	257	29,100	[25,000, 39,500]	2.86	[1.05, 5.65]
MV-PCI	267	26,900	[23,700, 31,900]	2.58	[0.928, 4.89]
CO-PCI vs. MV-PCI	524	2160	[− 2880, 10,100]	0.28	[− 0.721, 1.56]	7740	[− 130,000, 94,000]
No diabetes				QALYs		€/QALY
CO-PCI	241	27,300	[22,700, 39,800]	3.58	[1.39, 6.52]
MV-PCI	226	25,300	[22,000, 30,700]	3.24	[1.19, 5.72]
CO-PCI vs. MV-PCI	467	1970	[− 3380, 11,400]	0.346	[− 0.805, 1.69]	5680	[− 82,500, 66,900]
Diabetes				QALYs		€/QALY
CO-PCI	102	27,200	[21,900, 36,500]	1.88	[0.642, 4.12]
MV-PCI	116	24,700	[20,300, 30,500]	1.71	[0.615, 3.59]
CO-PCI vs. MV-PCI	218	2520	[− 5000, 11,400]	0.172	[− 0.605, 1.18]	14,700	[− 169,000, 196,000]

Figures are rounded to 3 significant figures. N represents the distribution of participating patients according to subgroup characteristics

CO-PCI culprit only percutaneous revascularisation, MV-PCI multivessel percutaneous revascularisation.